June 01, 2026

UTRGV School of Medicine research team identifies

new biomarker that could improve ALS diagnosis

Researchers at the UTRGV School of Medicine have identified a promising new biomarker that could help change how amyotrophic lateral sclerosis (ALS) is detected and studied, marking another step forward for biomedical research in the Rio Grande Valley. 



The discovery offers hope for earlier diagnosis and improved monitoring of a disease that remains one of the most difficult neurological conditions to understand and treat. 


Read more here.

Sign for UTRGV School of Medicine with bold text in red and gray on a beige wall. Below, a red stripe displays UTRGV.edu/SOM in white.